A study published in July 2025 issue of Journal of Allergy and Clinical Immunology Global highlighted persistent challenges ...

Primary care physicians play a vital role in identifying red flags for rare eosinophilic diseases like HES and EGPA, enabling ...

Dosing of the first patient in Phase 2b marks an important transition of the RESOLVE trial from a Phase 2a open-label study ...

Eosinophilic gastrointestinal diseases are exponentially more prevalent among patients with atopic diseases compared with the ...

Discover a study that highlights dupilumab’s consistent efficacy in eosinophilic oesophagitis, even among patients with ...

Etrasimod led to sustained histological and endoscopic improvements in eosinophilic oesophagitis over 52 weeks, symptom improvement in patients without dilation, and was well tolerated. This trial ...

Keywords: eosinophilic esophagitis, non-invasive biomarkers, biomarkers, diagnosis, disease monitoring Citation: Noble S-L, Tyrrell R, Mules TC and Inns S (2025) Non-invasive biomarkers to diagnose ...

Patients with eosinophilic esophagitis in the US have high health care resource utilization costs, according to a retrospective national claims study.

Eosinophilic Esophagitis: Empowering Clinicians for Better Patient Outcomes This program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi.

To know more about Eosinophilic Esophagitis companies working in the treatment market, visit @ Eosinophilic Esophagitis Clinical Trials and FDA Approvals Table of Contents ...

Detection and classification of cell nuclei in histopathology images of cancerous tissue stained with the standard hematoxylin and eosin stain is a challenging task due to cellular heterogeneity. Deep ...

Conclusions EoE is a chronic esophageal inflammatory disease of undetermined pathology and physiology. In childhood, vague symptoms associated with GERD and feeding difficulties are the first ...